Tenet Healthcare (NYSE:THC) Hits New 12-Month High – Here’s What Happened

Tenet Healthcare Corporation (NYSE:THC)’s share price reached a new 52-week high on Tuesday . The company traded as high as $271.17 and last traded at $270.2950, with a volume of 94956 shares traded. The stock had previously closed at $264.56.

Analyst Ratings Changes

Several brokerages recently issued reports on THC. Stephens reaffirmed an “overweight” rating and set a $285.00 target price on shares of Tenet Healthcare in a research report on Monday, July 27th. Truist Financial upped their price objective on shares of Tenet Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a report on Tuesday, July 28th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $305.00 price objective on shares of Tenet Healthcare in a research report on Tuesday, July 28th. Morgan Stanley boosted their target price on shares of Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research report on Monday, July 27th. Finally, Raymond James Financial reaffirmed an “outperform” rating and issued a $285.00 price target on shares of Tenet Healthcare in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $273.00.

Tenet Healthcare Stock Up 1.9%

The firm has a market capitalization of $21.70 billion, a price-to-earnings ratio of 10.42, a price-to-earnings-growth ratio of 1.02 and a beta of 1.23. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The business has a fifty day moving average price of $212.24 and a two-hundred day moving average price of $204.56.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. During the same quarter in the previous year, the company posted $4.02 earnings per share. The company’s revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, equities analysts expect that Tenet Healthcare Corporation will post 20.97 earnings per share for the current year.

Insider Transactions at Tenet Healthcare

In related news, Director Tammy Romo sold 2,500 shares of the firm’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $260.83, for a total transaction of $652,075.00. Following the completion of the transaction, the director owned 28,284 shares of the company’s stock, valued at $7,377,315.72. This trade represents a 8.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Lisa Y. Foo sold 10,000 shares of the business’s stock in a transaction on Wednesday, July 29th. The shares were sold at an average price of $258.03, for a total transaction of $2,580,300.00. Following the transaction, the executive vice president owned 32,053 shares of the company’s stock, valued at $8,270,635.59. This represents a 23.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 41,375 shares of company stock valued at $9,793,347. 0.97% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. Swedbank AB increased its holdings in Tenet Healthcare by 14.7% in the fourth quarter. Swedbank AB now owns 146,133 shares of the company’s stock valued at $29,040,000 after buying an additional 18,750 shares in the last quarter. Hsbc Holdings PLC grew its position in shares of Tenet Healthcare by 3,478.7% during the 4th quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock valued at $53,269,000 after acquiring an additional 258,956 shares during the period. Jackson Creek Investment Advisors LLC increased its stake in shares of Tenet Healthcare by 235.6% in the 4th quarter. Jackson Creek Investment Advisors LLC now owns 9,032 shares of the company’s stock valued at $1,795,000 after purchasing an additional 6,341 shares in the last quarter. M&T Bank Corp raised its holdings in Tenet Healthcare by 1,944.8% in the 4th quarter. M&T Bank Corp now owns 104,304 shares of the company’s stock worth $20,727,000 after purchasing an additional 99,203 shares during the period. Finally, Brandywine Global Investment Management LLC boosted its position in Tenet Healthcare by 20.5% during the fourth quarter. Brandywine Global Investment Management LLC now owns 126,248 shares of the company’s stock worth $25,088,000 after purchasing an additional 21,435 shares in the last quarter. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.